retatrutide when will it be available Retatrutide: FDA approval time, trial results & weight loss RETATRUTIDE (RETA) – Research Peptide

It's not a good thing

As of April 2026, retatrutide is not approved by the FDA, is not approved by the EMA, and has no active approval in any major regulatory jurisdiction

ABX Apps does not have a paid commercial relationship with Eli Lilly, Novo Nordisk, or any GLP-1 manufacturer

Reputable compounding pharmacies should be willing to provide CoA documentation upon request

Important Considerations Ozempic is a prescription medication and should be used only under the guidance of a healthcare professional The cost of Ozempic is not a substitute for a healthy lifestyle, including a balanced diet and regular exercise

This product is intended solely for research purposes and all product information provided on this website is intended for educational purposes only